ID: ALA609514

Max Phase: Preclinical

Molecular Formula: C13H19N4O11P

Molecular Weight: 438.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1ccn(C2O[C@H](COP(=O)(O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]2O)c(=O)n1

Standard InChI:  InChI=1S/C13H19N4O11P/c14-7-1-2-17(13(24)15-7)11-10(21)9(20)6(28-11)4-27-29(25,26)16-5(12(22)23)3-8(18)19/h1-2,5-6,9-11,20-21H,3-4H2,(H,18,19)(H,22,23)(H2,14,15,24)(H2,16,25,26)/t5-,6+,9+,10+,11?/m0/s1

Standard InChI Key:  FDQHTCAEJRXJHY-WLJLNKNQSA-N

Associated Targets(non-human)

CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 438.29Molecular Weight (Monoisotopic): 438.0788AlogP: -2.92#Rotatable Bonds: 9
Polar Surface Area: 243.76Molecular Species: ACIDHBA: 11HBD: 7
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 8#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.41CX Basic pKa: CX LogP: -3.87CX LogD: -11.87
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.19Np Likeness Score: 1.21

References

1. Whalen LJ, McEvoy KA, Halcomb RL..  (2003)  Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.,  13  (2): [PMID:12482445] [10.1016/s0960-894x(02)00735-7]

Source